Form 4 for RCEL AVITA Medical, Inc.
Accepted 2024-01-05 00:00:00 ET · period of report 2023-11-30 · accession 0000950170-24-002570 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-05 | 2023-11-30 | RCEL | Shiroma Donna | GC | A - Grant | $9.06 | +1,469 | 43.7K | +3% | +$13.3K |
| D | 2024-01-05 | 2024-01-03 | RCEL | Shiroma Donna | GC | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-30 | A | A | 1,469 | $9.06 | 43,726 | D | — | — | (F1) These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase which began July 1, 2023 and ended November 30, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Company's stock on November 30, 2023 (the purchase date of the offering period). (F2) Includes unvested RSUs |
| 2 | Derivative | Stock Options (Right to Buy) | 2024-01-03 | A | A | 100,000 | $0.00 | 100,000 | D | $12.64 · — to 2033-01-03 | 100,000 Common Stock | (F3) These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date. |